brexucabtagene autoleucelbrexi-celtisagenlecleucelaxicabtagene ciloleuceltisa-celaxi-celmyelomatertiary oncology centrechemo refractory aggressive B-cell lymphomas
…l (axi-cel), 31 (42%) tisagenlecleucel (tisa-cel), and 11 (16%) brexucabtagene autoleucel (brexi-cel). Mean V2Vt was 48±19 days (median 42) for axi-cel, …